Globus Medical Inc
GMED· NYSE
Released Aug 4, 2022, after the close
10-Q filed Aug 4, 2022, 35 days after period end · 0001562762-22-000341
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $263.65M | $251.02M | $148.92M | $194.54M |
| Net Income | $54.59M | $41.55M | -$20.84M | $38.16M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.53 |
| $0.40 |
| -$0.21 |
| $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.